Chemomab Therapeutics Ltd. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-04-28: Form DEF 14A; Period of report 2022-04-28; Description DEF 14A; Document zk2227688.htm.
- 2022-01-05: Form DEF 14A; Period of report 2022-01-05; Description DEF 14A; Document zk2227012.htm.
- 2021-09-17: Form DEF 14A; Period of report 2021-09-17; Description DEF 14A; Document zk2126591.htm.
- 2021-06-14: Form DEF 14A; Period of report 2021-06-14; Description DEF 14A; Document zk2126186.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-04-28 | DEF 14A | 2022-04-28 | DEF 14A | zk2227688.htm |
| 2022-01-05 | DEF 14A | 2022-01-05 | DEF 14A | zk2227012.htm |
| 2021-09-17 | DEF 14A | 2021-09-17 | DEF 14A | zk2126591.htm |
| 2021-06-14 | DEF 14A | 2021-06-14 | DEF 14A | zk2126186.htm |
| 2020-04-06 | DEF 14A | 2020-04-23 | DEF 14A | tm2014157-2_def14a.htm |